Ajanta Pharma

15 articles about Ajanta Pharma

• Ajanta Pharma Announces the Launch of Aripiprazole Tablets

  11/17/2016

• Ajanta Pharma Announces The Launch Of Voriconazole Tablets

  11/7/2016

• Ajanta Pharma Announces The Launch Of Amlodipine + Olmesartan Medoxomil Tablets

  11/2/2016

• Ajanta Pharma Announces The Launch Of Omeprazole And Sodium Bicarbonate Powder For Oral Suspension

  9/26/2016

• Ajanta Pharma Announces The Launch Of Almotriptan Malate Tablets

  7/19/2016

• Ajanta Pharma Announces The Approval And Launch Of Omeprazole And Sodium Bicarbonate Capsules

  7/19/2016

• Ajanta Pharma Announces The Launch Of Memantine Hydrochloride Tablets

  6/15/2016

• Ajanta Pharma Announces The Launch Of Levetiracetam Tablets

  3/24/2016

• Ajanta Pharma Announces The Launch Of Montelukast IR Tablets And Montelukast Chewable Tablets

  12/4/2015

• Ajanta Pharma Announces The Launch Of Montelukast Sodium Oral Granules

  11/16/2015

• Ajanta Pharma Announces The Launch Of Risperidone Tablets

  5/9/2014

• Ajanta Pharma Succeeds in Revoking 2 Allergenics, Inc. Patents

  8/12/2013

• Breckenridge Pharmaceutical, Inc. Announces Agreement With Ajanta Pharma to Market Risperidone Tablets

  10/4/2012

• Medicago, Inc. Signs MOU with Ajanta Pharma for Commercial Development of Influenza Vaccines in India and Other Territories

  8/20/2009

• Prollenium Medical Technologies Announces Partnership Agreement with Ajanta Pharma to Market Revanesse(R) in India

  9/17/2007